Utah Medical Products, Inc.
UTMD
$64.51
-$0.48-0.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.57% | -7.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.57% | -7.82% | |||
| Cost of Revenue | -9.02% | -10.15% | |||
| Gross Profit | 0.34% | -6.07% | |||
| SG&A Expenses | -4.97% | -8.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.19% | -8.60% | |||
| Operating Income | 6.63% | -6.03% | |||
| Income Before Tax | 2.45% | -6.13% | |||
| Income Tax Expenses | 7.04% | -20.35% | |||
| Earnings from Continuing Operations | 1.48% | -2.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.48% | -2.47% | |||
| EBIT | 6.63% | -6.03% | |||
| EBITDA | 3.23% | -5.06% | |||
| EPS Basic | 1.88% | -2.17% | |||
| Normalized Basic EPS | 4.39% | -5.50% | |||
| EPS Diluted | 1.97% | -2.22% | |||
| Normalized Diluted EPS | 4.39% | -5.50% | |||
| Average Basic Shares Outstanding | -0.39% | -0.31% | |||
| Average Diluted Shares Outstanding | -0.39% | -0.31% | |||
| Dividend Per Share | 0.00% | 1.64% | |||
| Payout Ratio | 0.00% | 0.01% | |||